Tag Archive > Ventricular Ejection Fraction

Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation

Paris, November 30 (ots/PRNewswire) – – First New Anti-Arrhythmic Drug to be Approved in the European Union in the Last 10 Years Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the European Commission has granted marketing authorization for Multaq(R) (dronedarone – 400mg Tablets) in all 27 European member states. This approval follows the European [...]

Continue reading

, , , , , , , , , , , , , , , , , ,

Ferinject®: FAIR-HF study meets primary endpoints in patients with Iron Deficiency and Chronic Heart Failure

(pressebox) Bern, 02.10.2009, Vifor Pharma has reached an important milestone in its clinical development program: The FAIR-HF Study – a study assessing Ferinject® (ferric carboxymaltose) in patients with iron deficiency (with and without anaemia) and chronic heart failure – was recently completed and has met the primary endpoints. The detailed results will be presented at [...]

Continue reading

, , , , , , , , , , , , , , , , , , ,